COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.
Antiretroviral therapy is medical prescriptions used for the treatment of HIV, which are mainly applied to manage the infection of a patient from the HIV virus. There are numerous types of combinations of antiretroviral treatments available in the market, which can stop the growth of the virus.
Increasing cases of HIV/AIDS worldwide are driving the antiretroviral therapy market. The growth in the antiretroviral therapy market is supported by various factors including the rising prevalence of HIV, growing access to antiretroviral therapy, increasing prevalence of mother-to-child transmission of HIV, and increasing intake of PrEP.
Drug Type Outlook
Based on drug class, the market is segmented into Integrase Inhibitors, Protease Inhibitors, Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), and Others. The key factors contributing to the growth of the Multi-class Combination Products are the rising burden of HIV and new drug approval. According to WHO, around 770,000 people died from HIV in 2018. Many companies are developing innovative products for the treatment of HIV patients, which help them take a competitive market position in the global antiretroviral market. Apart from this, many companies are investing more on R&D activities to develop new series of product to cater the market demand.
Regional Outlook
The North America region is dominating the global antiretroviral therapy treatment market in 2020. The growth of the region can be attributed to a high ART coverage rate and rising emphasis on prescribed branded drugs. In addition, the National Institutes of Health (NIH), United States, represents the largest public investment in HIV/AIDS research in the world, which is expected to fuel the market growth.
The consumption of ARV in African region is increasing due to the growing number of HIV cases, low price of ARV, and the initiatives take by international bodies such as WHO and international NGOs. These are some of the important factors for the rapid growth of the antiretroviral therapy market in this region.
Competitive Landscape
These major market players are involved in the research and development of novel antiviral drugs, particularly for the treatment of HIV. At present, the major companies operating in the anti-retroviral market are improving their research and development capabilities and are trying to make collaboration, mergers & acquisitions, along with exploring new market opportunities in the geographic regions. The global players in the anti-retroviral drugs market are - AbbVie Inc., Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, Gilead Sciences, Merck & Co, Inc., Mylan N.V., and ViiV Healthcare.
By Drug Type:
By Region
North America Antiretroviral Therapy Market
Europe Antiretroviral Therapy Market
Asia Pacific Antiretroviral Therapy Market
Middle East & Africa Antiretroviral Therapy Market
South America Antiretroviral Therapy Market
Major Companies
Recent Developments
Objectives of this report:
Customization:
This study is customized to meet your specific requirements:
For more information, contact: [email protected]
Single User (PDF)
3850Multi User (PDF)
5150Enterprise User (PDF)
7650Avail customized purchase options to meet your exact research needs.
Detailed scope covering all the major segments in the market
In line data validations to ensure data precision
Market recommendations supporting decision making processes
Round the clock analyst support to resolve your queries
Up to 15% additional free customization to meet your specific requirements